These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23438790)

  • 1. Neonatal toxicity following maternal citalopram treatment.
    Eleftheriou G; Butera R; Cotti Cottini F; Bonati M; Farina M
    Fetal Pediatr Pathol; 2013 Oct; 32(5):362-6. PubMed ID: 23438790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram serum and milk levels in mother and infant during lactation.
    Franssen EJ; Meijs V; Ettaher F; Valerio PG; Keessen M; Lameijer W
    Ther Drug Monit; 2006 Feb; 28(1):2-4. PubMed ID: 16418683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine withdrawal syndrome in the newborn.
    Anbu AT; Theodore A
    Indian Pediatr; 2006 Jan; 43(1):66-9. PubMed ID: 16465011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal abstinence syndrome due to prenatally citalopram exposure: A case report.
    Erol S; Ozcan B; Celik IH; Bas AY; Demirel N
    Arch Argent Pediatr; 2017 Dec; 115(6):e424-e427. PubMed ID: 29087127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.
    Kwon P; Lefkowitz W
    Pediatr Ann; 2008 Mar; 37(3):128-30. PubMed ID: 18411854
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal morbidity due to maternal use of two antidepressant drugs.
    Jwa S; Wada Y; Yamamoto M; Sumida Y
    Pediatr Int; 2018 Jan; 60(1):87-88. PubMed ID: 29235219
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
    J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
    Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
    J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.
    Koren G; Finkelstein Y; Matsui D; Berkovich M
    J Obstet Gynaecol Can; 2009 Apr; 31(4):348-350. PubMed ID: 19497154
    [No Abstract]   [Full Text] [Related]  

  • 11. Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.
    Koren G; Moretti M; Kapur B
    J Obstet Gynaecol Can; 2006 Apr; 28(4):299-301. PubMed ID: 16776907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SSRI treatment during pregnancy: are we asking the right questions?
    Wisner KL
    Depress Anxiety; 2010 Aug; 27(8):695-8. PubMed ID: 20694964
    [No Abstract]   [Full Text] [Related]  

  • 13. Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).
    Santos RP; Pergolizzi JJ
    J Perinatol; 2004 Jun; 24(6):392-4. PubMed ID: 15167880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy.
    Bot P; Semmekrot BA; van der Stappen J
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F153. PubMed ID: 16492956
    [No Abstract]   [Full Text] [Related]  

  • 15. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
    Nordeng H; Lindemann R; Perminov KV; Reikvam A
    Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram.
    Potts AL; Young KL; Carter BS; Shenai JP
    J Perinatol; 2007 Feb; 27(2):120-2. PubMed ID: 17262045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels.
    Knoppert DC; Nimkar R; Principi T; Yuen D
    Ther Drug Monit; 2006 Feb; 28(1):5-7. PubMed ID: 16418684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged neonatal complications after in utero exposure to fluoxetine.
    Alehan F; Saygi S; Tarcan A; Gürakan B
    J Matern Fetal Neonatal Med; 2008 Dec; 21(12):921-3. PubMed ID: 18985556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.